BIO-Europe Spring: Leading life sciences partnering event pivots to deliver dealmaking
opportunities in a new format during very unusual times. With just 16 days to plan, EBD Group transformed BIO-Europe Spring from a physical event held in Paris to a fully digital solution where 1,700 delegates around the world participated in virtual partnering meetings and panels.
From Novartis to Syncona
AppointmentsLondon-based Syncona Ltd announces the appointment of Danny Bar-Zohar as Syncona Partner, starting mid of April.
Bone Therapeutics bags €11m
Latest NewsBelgian Bone Therapeutics SA has secured €11m to foster development of its late stage pipeline candidates.
Cevec launches ELEVECTA platform
Latest NewsCevec Pharmaceuticals GmbH has launched a new, scalable production platform for AAV gene therapy vectors.
Artes enters COVID-19 vaccine race
Latest NewsGerman vaccine developer ARTES Biotechnology GmbH will develop a COVID-19 subunit vaccine based on virus-like particles (VLP), which include two proteins of SARS-CoV-2.
Bayer, Novartis, and Trump convicted by Nature
Latest NewsThe politically overhyped use of old malaria drugs in combination with COVID-19-specific candidates has been demonstrated to be dangerous, reports Nature Medicine.
Drug from worms dampens autoimmune response
Latest NewsGerman researchers have isolated a substance from parasitic roundworm larvae to alleviate inflammation and treat asthma in a rodent model.
Fully digital partnering at BIO-Europe Spring 2020
Sponsored PublicationsBIO-Europe Spring: Leading life sciences partnering event pivots to deliver dealmaking
opportunities in a new format during very unusual times. With just 16 days to plan, EBD Group transformed BIO-Europe Spring from a physical event held in Paris to a fully digital solution where 1,700 delegates around the world participated in virtual partnering meetings and panels.
Life in a bubble – droplet science
BackgroundIt’s a discovery that revolutionises our fundamental understanding of cells. Tiny droplets called condensates that form through weak interactions between proteins and RNA are at the heart of many key biological processes. Dewpoint Therapeutics – the first start-up to harness the basic research for a new therapeutic platform technology – is now opening a facility in the German capital Berlin.
Nanolitre dispensing
ProductsThe acoustic dispensing technology of the Echo-Series Liquid Handlers has revolutionised the transfer of liquids.
Swiss biotech sector with robust growth
Latest NewsLast year, the biotechnology sector in Switzerland has continued its growth and proved to be a magnet for fresh capital and investment. This is revealed by the Swiss Biotech Report 2020.